Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cavallo

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Pain (London, England)|May 9, 2014
Self-reported recurrent pain and medicine use behaviours among 15-year olds: results from the international studyI Gobina, J Villberg, A Villerusa, et al.
Leukemia|October 31, 2003
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))A Palumbo, S Bringhen, A Bertola, et al.
Journal of Endocrinological Investigation|May 8, 2022
Hypersexuality as a tip of the iceberg of a primary psychopathology: a joined position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) and of the Italian Society of Psychopathology (SOPSI)E Limoncin, G Ciocca, G Castellini, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
WEARnCARE, a decision support system to enhance monitoring of motor performance in Parkinson's disease patient's journey<sup></sup>E Rovini, G Mancioppi, I Ragusa, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsT Guglielmelli, S Bringhen, S Rrodhe, et al.
The Journal of Experimental Medicine|November 7, 2001
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceP Nanni, G Nicoletti, C De Giovanni, et al.
The Journal of Experimental Medicine|August 4, 1998
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.
Veterinary and Comparative Oncology|May 6, 2016
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccinationL A Piras, F Riccardo, S Iussich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2022
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceG Avallone, F Cavallo, C Astrua, et al.
Leukemia|September 22, 2012
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patientsP Falco, F Cavallo, A Larocca, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Pain (London, England)|May 9, 2014
Self-reported recurrent pain and medicine use behaviours among 15-year olds: results from the international studyI Gobina, J Villberg, A Villerusa, et al.
Leukemia|October 31, 2003
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))A Palumbo, S Bringhen, A Bertola, et al.
Journal of Endocrinological Investigation|May 8, 2022
Hypersexuality as a tip of the iceberg of a primary psychopathology: a joined position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) and of the Italian Society of Psychopathology (SOPSI)E Limoncin, G Ciocca, G Castellini, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
WEARnCARE, a decision support system to enhance monitoring of motor performance in Parkinson's disease patient's journey<sup></sup>E Rovini, G Mancioppi, I Ragusa, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsT Guglielmelli, S Bringhen, S Rrodhe, et al.
The Journal of Experimental Medicine|November 7, 2001
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceP Nanni, G Nicoletti, C De Giovanni, et al.
The Journal of Experimental Medicine|August 4, 1998
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.
Veterinary and Comparative Oncology|May 6, 2016
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccinationL A Piras, F Riccardo, S Iussich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2022
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceG Avallone, F Cavallo, C Astrua, et al.
Leukemia|September 22, 2012
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patientsP Falco, F Cavallo, A Larocca, et al.
Pageof 15